8528 results
-
List item
Human medicine European public assessment report (EPAR): Blitzima (updated)
rituximab, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell
Date of authorisation: 13/07/2017,,
, Revision: 6, Authorised
-
List item
Human medicine European public assessment report (EPAR): Amglidia (updated)
glibenclamide, Diabetes Mellitus
Date of authorisation: 24/05/2018,, Revision: 2, Authorised
-
List item
Human medicine European public assessment report (EPAR): Eladynos (updated)
abaloparatide, Osteoporosis
Date of refusal: 07/01/2019, Refused -
List item
Human medicine European public assessment report (EPAR): Kigabeq (updated)
vigabatrin, Spasms, Infantile, Epilepsies, Partial
Date of authorisation: 20/09/2018, Revision: 1, Authorised -
List item
Human medicine European public assessment report (EPAR): Palonosetron Accord (updated)
Palonosetron, Vomiting, Nausea, Cancer
Date of authorisation: 26/05/2016,, Revision: 1, Authorised
-
List item
Human medicine European public assessment report (EPAR): Ameluz (updated)
5-aminolevulinic acid hydrochloride, Keratosis, Actinic, Carcinoma, Basal Cell
Date of authorisation: 13/12/2011, Revision: 13, Authorised -
List item
Human medicine European public assessment report (EPAR): Pregabalin Zentiva k.s. (updated)
pregabalin, Anxiety Disorders, Neuralgia, Epilepsy
Date of authorisation: 27/02/2017,, Revision: 4, Authorised
-
List item
Human medicine European public assessment report (EPAR): Relvar Ellipta (updated)
fluticasone furoate, vilanterol, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 13/11/2013, Revision: 17, Authorised -
List item
Human medicine European public assessment report (EPAR): Anoro Ellipta (previously Anoro) (updated)
umeclidinium bromide, vilanterol trifenatate, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 08/05/2014,, Revision: 10, Authorised
-
List item
Human medicine European public assessment report (EPAR): Mektovi (updated)
binimetinib, Melanoma
Date of authorisation: 20/09/2018,, Revision: 1, Authorised
-
List item
Veterinary medicine European public assessment report (EPAR): Zycortal (updated)
desoxycortone pivalate, Dogs
Date of authorisation: 06/11/2015, Revision: 1, Authorised -
List item
Human medicine European public assessment report (EPAR): Entyvio (updated)
vedolizumab, Colitis, Ulcerative, Crohn Disease
Date of authorisation: 22/05/2014,, Revision: 11, Authorised
-
List item
Human medicine European public assessment report (EPAR): Erivedge (updated)
vismodegib, Carcinoma, Basal Cell
Date of authorisation: 12/07/2013,
Date of refusal: 26/04/2013, Revision: 11, Authorised -
List item
Veterinary medicine European public assessment report (EPAR): Clomicalm (updated)
clomipramine, Dogs
Date of authorisation: 01/04/1998, Revision: 14, Authorised -
List item
Human medicine European public assessment report (EPAR): Adempas (updated)
riociguat, Hypertension, Pulmonary
Date of authorisation: 27/03/2014,,
, Revision: 9, Authorised
-
List item
Human medicine European public assessment report (EPAR): Juluca (updated)
dolutegravir sodium,rilpivirine hydrochloride, HIV Infections
Date of authorisation: 16/05/2018,,
, Revision: 1, Authorised
-
List item
Human medicine European public assessment report (EPAR): Neuraceq (updated)
florbetaben (18F), Radionuclide Imaging, Alzheimer Disease
Date of authorisation: 20/02/2014, Revision: 14, Authorised -
List item
Human medicine European public assessment report (EPAR): Volibris (updated)
Ambrisentan, Hypertension, Pulmonary
Date of authorisation: 20/04/2008,, Revision: 19, Authorised
-
List item
Veterinary medicine European public assessment report (EPAR): Nobilis IB 4-91 (updated)
live attenuated avian infectious bronchitis virus variant strain 4-91, Chicken
Date of authorisation: 09/06/1998, Revision: 13, Authorised -
List item
Veterinary medicine European public assessment report (EPAR): BTVPUR (updated)
bluetongue-virus serotype-1 antigen / bluetongue-virus serotype-8 antigen , Sheep, Cattle
Date of authorisation: 17/12/2010, Revision: 7, Authorised -
List item
Human medicine European public assessment report (EPAR): Copalia HCT (updated)
amlodipine, valsartan, hydrochlorothiazide, Hypertension
Date of authorisation: 03/11/2009, Revision: 13, Authorised -
List item
Human medicine European public assessment report (EPAR): Cimzia (updated)
Certolizumab pegol, Arthritis, Rheumatoid
Date of authorisation: 01/10/2009, Revision: 23, Authorised -
List item
Human medicine European public assessment report (EPAR): Brintellix (updated)
Vortioxetine, Depressive Disorder, Major
Date of authorisation: 18/12/2013, Revision: 12, Authorised -
List item
Human medicine European public assessment report (EPAR): MabThera (updated)
rituximab, Lymphoma, Non-Hodgkin, Arthritis, Rheumatoid, Leukemia, Lymphocytic, Chronic, B-Cell
Date of authorisation: 02/06/1998, Revision: 44, Authorised -
List item
Human medicine European public assessment report (EPAR): Keytruda (updated)
Pembrolizumab, Melanoma, Hodgkin Disease, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 16/07/2015,, Revision: 16, Authorised